IGF1 and liver disorder: In the IGF1/IRS1/Akt/mTOR pathway, decreased IGF-1 induced by liver disease and decreased ubiquitination of IRS-1 induced by epigenetic alterations block the pathway upstream and downstream respectively, leading to the development of sarcopenia.